Effectiveness of body powder for preventing groin rash among conscripts
Main Article Content
Abstract
Background: Groin rashes from Tinea cruris, Intertrigo, Erythrasma, and Candidiasis are common skin diseases in military careers. Although the diseases are not so fatal, they affect training efficiency and quality of life of soldiers. At present, there is still no study about the effectiveness of the anti-rash powder among military personnel in Thailand.
Objective: 1) To compare the incidence rate of groin rash between conscripts who use the anti-rash powder (experimental group) with those who use a commercial body powder (control group), and 2) To study the incidence of adverse events in the conscripts from powder use in both the experimental and control groups.
Method: A cluster randomized controlled trial was conducted among the selected 11 military training units in Bangkok, of which 7 and 4 units (with the accompanying eligible 937 and 911 conscripts recruited) were allocated into the experimental and control groups respectively. The powder use period was 10 weeks, during which the military training nurses in each training unit were requested to assess the occurrence of groin rash among the conscripts biweekly. Conscripts with newly developed groin rash were sent for further examination and treatment from a dermatologist at the Dermatology Department of Phramongkutklao Hospital.
Results: New groin rashes were developed among 217 and 276 conscripts respectively in the experimental and control groups. The corresponding incidence rates of 23.16 and 30.30 cases per 100 people per 10 weeks, which were statistical significantly different (p = 0.001). Further analysis by taking into account the potential confounding factors (age, educational level, history of previous fungal infection, and history of getting into the water during the previous two weeks), the adjusted rate ratio (95% Confidence interval) was 0.76 (0.63, 0.90) (p = 0.002). In addition, the potential complicating symptoms were not more frequent among the experimental than the control groups.
Conclusions: The anti-rash body powder is effective in preventing the groin rash among military conscripts in Thailand.
Article Details
References
2. Bae JM, Ha B, Lee H, Park CK, Kim HJ, Park YM. Prevalence of common skin diseases and their associated factors among military personnel in Korea: a cross-sectional study. J Korean Med Sci 2012;27:1248-54.
3. Gan WH, Low R, Koh D. Dermatological conditions in military conscripts. Occup Med (Lond) 2013;63:435-8.
4. Sasmaz S, Celik M. Skin diseases in Turkish soldiers. Dermatol Sin 2011;29:44-6.
5. Gatt P, Pace J. Environmental skin diseases in military personnel. Clin Dermatol 2002;20:420-4.
6. Senel E, Dogruer Senel S, Salmanoglu M. Prevalence of skin diseases in civilian and military population in a Turkish military hospital in the central Black Sea region. J R Army Med Corps 2015;161:112-5.
7. Kaushik N, Pujalte GG, Reese ST. Superficial Fungal Infections. Prim Care 2015;42:501-16.
8. Kalra MG, Higgins KE, Kinney BS. Intertrigo and secondary skin infections. Am Fam Physician 2014;89:569-73.
9. Nobles T, Miller RA. Intertrigo. StatPearls. Treasure Island (FL): StatPearls Publishing
StatPearls Publishing LLC.; 2018.
10. Wolf R, Oumeish OY, Parish LC. Intertriginous eruption. Clin Dermatol 2011;29:173-9.
11. Schieke SM, Grag A. Superficial fungal infection. In: Goldsmith LA, Katz SI, Goldsmith BA, Paller AS, Leffell DJ, Wolff K, editors. Fitapatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p. 2278-328.
12. Leite Junior DP, Yamamoto AC, Martins ER, Teixeira AF, Hahn RC. Species of Candida isolated from anatomically distinct sites in military personnel in Cuiaba, Mato Grosso, Brazil. An Bras Dermatol 2011;86:675-80.
13. Dermnet New Zealand. Tinea cruris [internet]. 2003. [cited 2018 Nov 2]. Available from: https://www.dermnetnz.org/topics/tinea-cruris.
14. Ingordo V, Naldi L, Fracchiolla S, Colecchia B. Prevalence and risk factors for superficial fungal infections among Italian Navy Cadets. Dermatology 2004;209:190-6.
15. Keita S, Faye O, Traore A, Dicko A, Berthe S, Traore P, et al. Dermatitis of the folds in black Africans in Bamako, Mali. Int J Dermatol 2012;51 Suppl 1:37-40, 1-4.
16. Drug.com. Drug.com. Gold Bond; Medicated Body [internet]. 2018. [cited 2019 Jan 3]. Available from: https://www.drugs.com/cdi/gold-bond-medicated-body.html.
17. Souza AD, Strober BE. Topical therapy. In: Goldsmith LA, Katz SI, Goldsmith BA, Paller AS, Leffell DJ, Wolff K, editors. Fitapatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p. 2644-713.
18. Benbow M. Use of talcum powder. J Wound Care 2001;10:22.